Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Oral VK2735

Oral VK2735 for Weight Management Phase 3 (SUNRISE 1)

Viking Therapeutics · Phase 3 · Not yet recruiting · Enrollment 560

NCT07868835

ArmPopulationDoseWeeksEstimandWeight change
Placebo AssignmentObesity or overweightn/rn/rn/rn/r
Active Assignment (Dose 1)Obesity or overweightn/rn/rn/rn/r
Active Assignment (Dose 2)Obesity or overweightn/rn/rn/rn/r
Active Assignment (Dose 3)Obesity or overweightn/rn/rn/rn/r